However, as these mice age, they progress from the neutropenic phenotype to a myeloid proliferative condition and later to an AML-like disease, showing first of all, that mutations in Cebpa result in a predisposition to myeloid diseases. This evidence concerns the gene CEBPA and acute myeloid leukemia.